Investor Watch Series | Funding- Who to Watch | S1 E1

Mar 7, 2020 | Digital Media, Investor Watch Series, Video


Welcome To Investor Watch

In this series will be going over trials, research and other clinical verticals that receive funding. Below are the ones we cover in this episode:

  • Texas-Based CPRIT Allocates $21M to Texas-based Cancer Investigators & Venture
  • NeoTX Therapeutics Secures $45m to Conduct Phase I Clinical Trial leveraging the Proprietary Selective T Cell Redirection (STR) Platform
  • Solving Rising Behavioral Health Challenges with Virtual Reality? Oxford University Spinoff Raises $12.5m
  • Short Sellers Pursue Principia Biopharma Arguing the Addressing Autoimmune Disease with BTK Inhibitors Flawed Strategy
  • Disease with BTK Inhibitors Flawed Strategy


Pin It on Pinterest